Subscribe to Newsletter
Manufacture Contract Development Services, Small Molecules, Contract Manufacturing Services

Embracing Technologies & Enhancing Outcomes

sponsored by Johnson Matthey

Experts from Johnson Matthey examine some of the hottest trends in drug development. With many new drugs suffering from poor solubility and bioavailability, Alan Chorlton discusses why solid state science is more important than ever before, while Paul Evans examines the innovator drugs today that will be tomorrow’s generic targets. Looking to the medicines of the future, Beatriz Dominguez and Ahir Pushpanath explain how enzyme engineering has opened up new possibilities in biocatalysis, and Kevin Hennessy looks at the growing interest in cannabinoid drug development. Finally, Nick Shackley gives his view on why outsourcing can help companies get the most from their molecules.

>> Download the PDF
Receive content, products, events as well as relevant industry updates from The Medicine Maker and its sponsors.
Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register